<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04820218</url>
  </required_header>
  <id_info>
    <org_study_id>EYEQUE - 008</org_study_id>
    <nct_id>NCT04820218</nct_id>
  </id_info>
  <brief_title>At-home Testing Refraction Results With Best Corrected Visual Acuity (BCVA) Outcomes in Adults</brief_title>
  <official_title>An Open Label Study to Evaluate At-home Testing Refraction Results With Best Corrected Visual Acuity (BCVA) Outcomes in Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EyeQue Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>EyeQue Corp.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is aimed at examining the BCVA from try-on glasses constructed from measurements&#xD;
      from the EyeQue VisionCheck.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is aimed at examining the BCVA from try-on glasses constructed from measurements&#xD;
      from the EyeQue VisionCheck. The refraction measurements that users obtain from the&#xD;
      VisionCheck are from testing at-home and without additional guidance other than that normally&#xD;
      provided to those purchasing the device.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 21, 2021</start_date>
  <completion_date type="Anticipated">July 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Subjects who had previously tested with an EyeQue ophthalmic refraction device and ordered try-on glasses will be asked to measure their visual acuity with and without their try-on glasses.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity with and without try-on glasses</measure>
    <time_frame>Visit 1: Day 0</time_frame>
    <description>Visual Acuity with and without try-on glasses</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Visual Impairment</condition>
  <condition>Myopia</condition>
  <condition>Hyperopia</condition>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>Without Try-on glasses</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects will be asked to measure their visual acuity without their try-on glasses</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>With Try-on glasses</intervention_name>
    <description>Subjects will be asked to measure their visual acuity with their try-on glasses</description>
    <arm_group_label>Without Try-on glasses</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or Female&#xD;
&#xD;
          2. Ages 30+&#xD;
&#xD;
          3. Had purchased an EyeQue refraction device.&#xD;
&#xD;
          4. Obtained EGN's from the EyeQue refraction device.&#xD;
&#xD;
          5. Ordered Try-On glasses based on EyeQue EyeGlass Numbers.&#xD;
&#xD;
          6. Allow use for this study the VisionCheck refraction and try-on glasses measurements,&#xD;
             taken prior to study participation.&#xD;
&#xD;
        Subject Exclusion Criteria, Subjects that by self-report:&#xD;
&#xD;
          1. Do not have a command of the English language.&#xD;
&#xD;
          2. Lack the ability to follow instructions.&#xD;
&#xD;
          3. Lack binocular vision.&#xD;
&#xD;
          4. Are Color-blind.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Noam Sapiens, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>EyeQue Corporation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paul TANPIENGCO</last_name>
    <phone>5104558168</phone>
    <email>paul.tanpiengco@eyeque.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>EyeQue</name>
      <address>
        <city>Newark</city>
        <state>California</state>
        <zip>94560</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul TANPIENGCO</last_name>
      <phone>510-455-8168</phone>
      <email>paul.tanpiengco@eyeque.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 23, 2021</study_first_submitted>
  <study_first_submitted_qc>March 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2021</study_first_posted>
  <last_update_submitted>April 26, 2021</last_update_submitted>
  <last_update_submitted_qc>April 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vision Disorders</mesh_term>
    <mesh_term>Vision, Low</mesh_term>
    <mesh_term>Astigmatism</mesh_term>
    <mesh_term>Hyperopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

